CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 131 filers reported holding CYTOMX THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.09 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $1,546,000 | -21.8% | 357,134 | -8.0% | 0.00% | -100.0% |
| Q3 2021 | $1,977,000 | +5.6% | 388,320 | +31.3% | 0.00% | 0.0% |
| Q2 2021 | $1,872,000 | -17.4% | 295,718 | +0.9% | 0.00% | 0.0% |
| Q1 2021 | $2,266,000 | +35.1% | 293,183 | +14.5% | 0.00% | 0.0% |
| Q4 2020 | $1,677,000 | -2.4% | 255,965 | -1.0% | 0.00% | 0.0% |
| Q3 2020 | $1,719,000 | +1.3% | 258,535 | +26.9% | 0.00% | 0.0% |
| Q2 2020 | $1,697,000 | +5.9% | 203,735 | -2.5% | 0.00% | 0.0% |
| Q1 2020 | $1,602,000 | +9.7% | 208,925 | +18.8% | 0.00% | 0.0% |
| Q4 2019 | $1,461,000 | +1.6% | 175,856 | -9.8% | 0.00% | 0.0% |
| Q3 2019 | $1,438,000 | – | 194,862 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 5,803,700 | $25,130,000 | 0.91% |
| Altium Capital Management LP | 663,800 | $2,874,000 | 0.79% |
| Rubric Capital Management LP | 2,406,449 | $10,420,000 | 0.49% |
| RTW INVESTMENTS, LP | 6,029,700 | $26,109,000 | 0.38% |
| Orbimed Advisors | 3,214,509 | $13,919,000 | 0.18% |
| TANG CAPITAL MANAGEMENT LLC | 152,345 | $660,000 | 0.13% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 980,085 | $4,244,000 | 0.12% |
| Point72 Asset Management, L.P. | 6,303,025 | $27,292,000 | 0.11% |
| Sender Co & Partners, Inc. | 40,720 | $176,000 | 0.09% |
| Manteio Capital LLC | 15,067 | $65,000 | 0.08% |